Ransomware victim disclosure
← All victimsCrystal Pharmatech
Claimed by Eclipse · listed 18 hours ago
Status timeline
- ListedAug 23, 2026
- Data leakeddate unknown
At a glance
- Group
- Eclipse
- Status
- Data leaked
- Country
- United States
- Sector
- Healthcare
- Listed on leak site
- Aug 23, 2026
About the victim
AI dossier — public-source company profileCrystal Pharmatech is a technology-driven CDMO/CRO established in 2010 that specializes in materials science, formulation development, and drug manufacturing services. With R&D and manufacturing centers across Suzhou, New Jersey, San Francisco, and Toronto, the company serves the pharmaceutical industry with services including API solid-state research, crystallization, preformulation, formulation development, clinical supply, and biologics services.
- Industry
- Contract Research Organization (CRO) / Contract Development and Manufacturing Organization (CDMO) — Pharmaceutical
- Address
- Multiple locations: Suzhou (China), New Jersey (USA), San Francisco (USA), Toronto (Canada)
- Founded
- 2010
Attack summary
Severity: medium — Data has been published by the threat actor and the company operates in a regulated sector (pharmaceuticals) handling potentially sensitive R&D and manufacturing information, but the leak post provides no inventory of compromised data or proof files, limiting confidence in the breach scope.Eclipse claims to have breached Crystal Pharmatech and published data. The leak post does not specify what data was exfiltrated, the nature of the attack (encryption vs. exfiltration or both), or the scope of affected information.
What the group claims
Crystal Pharmatech is a technology-driven contract research organization (CRO) that focuses on materials science and engineering for drug development. Established in 2010 and have R&D centers located in Suzhou (China), New Jersey, San Francisco (USA), and Toronto (Canada). Also its key differentiator is integrated and specialized services, including API solid-state research, crystallization, preformulation, formulation development and manufacturing, clinical supply.
Sources
Source
Indexed 18 hours agoThis page surfaces a public ransomware disclosure indexed by Darkfield. Original posts come from the operator's own leak site; we cross-check against ransomware.live, RansomLook and RansomWatch where applicable. Share this URL freely.
Is this your supplier? Your competitor? You?
Pro plans monitor your domain, corporate emails, and crypto wallets across every new ransomware leak-site post, breach dump and Telegram callout — alerts within 5 minutes.

